Charles Schwab’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-480,794
| Closed | -$32.7M | – | 3620 |
|
|
2022
Q3 | $32.7M | Buy |
480,794
+47,651
| +11% | +$3.25M | 0.01% | 1036 |
|
|
2022
Q2 | $13.8M | Sell |
433,143
-2,357
| -0.5% | -$75.3K | ﹤0.01% | 1644 |
|
|
2022
Q1 | $15.1M | Buy |
435,500
+13,793
| +3% | +$478K | ﹤0.01% | 1727 |
|
|
2021
Q4 | $12.3M | Buy |
421,707
+20,030
| +5% | +$586K | ﹤0.01% | 1888 |
|
|
2021
Q3 | $10.2M | Sell |
401,677
-22,378
| -5% | -$570K | ﹤0.01% | 1996 |
|
|
2021
Q2 | $14.9M | Buy |
424,055
+127,104
| +43% | +$4.45M | ﹤0.01% | 1777 |
|
|
2021
Q1 | $12.1M | Sell |
296,951
-18,412
| -6% | -$750K | ﹤0.01% | 1844 |
|
|
2020
Q4 | $13.7M | Buy |
315,363
+4,717
| +2% | +$204K | 0.01% | 1666 |
|
|
2020
Q3 | $17.1M | Buy |
310,646
+957
| +0.3% | +$52.8K | 0.01% | 1307 |
|
|
2020
Q2 | $19.6M | Sell |
309,689
-93,219
| -23% | -$5.89M | 0.01% | 1193 |
|
|
2020
Q1 | $20.6M | Buy |
402,908
+27,813
| +7% | +$1.42M | 0.01% | 993 |
|
|
2019
Q4 | $29.8M | Buy |
375,095
+8,502
| +2% | +$676K | 0.02% | 942 |
|
|
2019
Q3 | $17.8M | Buy |
366,593
+41,228
| +13% | +$2M | 0.01% | 1224 |
|
|
2019
Q2 | $17.1M | Buy |
325,365
+11,148
| +4% | +$586K | 0.01% | 1245 |
|
|
2019
Q1 | $16.6M | Buy |
314,217
+19,493
| +7% | +$1.03M | 0.01% | 1226 |
|
|
2018
Q4 | $12.1M | Buy |
294,724
+13,868
| +5% | +$569K | 0.01% | 1335 |
|
|
2018
Q3 | $10.7M | Buy |
280,856
+22,713
| +9% | +$863K | 0.01% | 1591 |
|
|
2018
Q2 | $11.7M | Buy |
258,143
+45,038
| +21% | +$2.04M | 0.01% | 1487 |
|
|
2018
Q1 | $10.3M | Buy |
213,105
+36,661
| +21% | +$1.77M | 0.01% | 1471 |
|
|
2017
Q4 | $6.94M | Buy |
176,444
+22,325
| +14% | +$879K | 0.01% | 1732 |
|
|
2017
Q3 | $4.79M | Buy |
154,119
+4,485
| +3% | +$139K | ﹤0.01% | 1894 |
|
|
2017
Q2 | $4.09M | Buy |
149,634
+38,829
| +35% | +$1.06M | ﹤0.01% | 1924 |
|
|
2017
Q1 | $4.08M | Buy |
110,805
+44,383
| +67% | +$1.64M | ﹤0.01% | 1871 |
|
|
2016
Q4 | $960K | Buy |
66,422
+3,696
| +6% | +$53.4K | ﹤0.01% | 2440 |
|
|
2016
Q3 | $1.45M | Buy |
62,726
+30,436
| +94% | +$702K | ﹤0.01% | 2284 |
|
|
2016
Q2 | $536K | Buy |
32,290
+12,536
| +63% | +$208K | ﹤0.01% | 2564 |
|
|
2016
Q1 | $314K | Buy |
19,754
+408
| +2% | +$6.49K | ﹤0.01% | 2754 |
|
|
2015
Q4 | $626K | Buy |
19,346
+13,306
| +220% | +$431K | ﹤0.01% | 2543 |
|
|
2015
Q3 | $255K | Buy |
+6,040
| New | +$255K | ﹤0.01% | 2886 |
|